IDEX IDEX BIOMETRICS ASA

IDEX Biometrics - Subscription of shares in the subsequent offering

IDEX Biometrics - Subscription of shares in the subsequent offering

Oslo, Norway – 26 November 2024. Following the private placement on 16. September 2024 (the “Private Placement”), IDEX Biometrics ASA (the “Company”) is conducting a subsequent offering (repair issue) of up to 140 million shares at NOK 0.15 per share. Shareholders who participate in this offering will also receive warrants to subscribe for additional shares at the same price (NOK 0.15 per share).

Deadline for subscription is 29 November 2024 at 16:30 CET.

For more information and a link to the subscription:

Shareholders who held shares in the Company at the close of business on 16 September 2024, but did not participate in the Private Placement, may participate in the subsequent offering and buy shares in IDEX Biometrics at the same terms. Reference is also made to the separate notice “Approved Prospectus” on 13 November 2024.

Key Terms:

  • Shareholders holding shares on 16. September 2024 (as registered in the Norwegian Securities Depositary (Euronext VPS or the “VPS”) two trading days thereafter (the “Record Date”), have received 0.5485 subscription rights per share held.
  • Shareholders may subscribe for their rights at the subscription price of NOK 0.15 per share.
  • Shareholders will without cost be allocated additional warrants.
  • For every two shares subscribed, shareholders will receive two warrants, at an exercise price of NOK 0.15 each.
  • Oversubscription is allowed.
  • Further details are available in the prospectus and subscription form.

For further information contact:

Marianne Bøe, Head of Investor Relations

Kristian Flaten, CFO

E-mail: 

Tel: 9

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.

For more information, visit 

Trademark Statement

IDEX, IDEX Biometrics and the IDEX logo are trademarks owned by IDEX Biometrics ASA. All other brands or product names are the property of their respective holders.

About this notice:

This notice was issued by Marianne Bøe, Head of Investor Relations, on 26 November 2024 at 09:00 CET on behalf of IDEX Biometrics ASA.



EN
26/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IDEX BIOMETRICS ASA

 PRESS RELEASE

Mandatory disclosure of holding and notice of trade in IDEX Biometrics...

Mandatory disclosure of holding and notice of trade in IDEX Biometrics - 26 August 2025 Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider. Tranche 2 of the private placement amounted to 4,359,315 shares. All shares was lent, not sold, by CEO and CFO Anders Storbråten. The shares – 4,359,315 – is now returned to Anders Storbråten. Storbråten and close relations hold 11,555,213 shares or 20,3 % shares of the tot...

 PRESS RELEASE

Mandatory disclosure of holding and notice of trade in IDEX Biometrics...

Mandatory disclosure of holding and notice of trade in IDEX Biometrics – 23 August 2025 Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share, split in two tranches. IDEX discloses the following information on behalf of primary insiders. In tranche 2 of the private placement, including underwriting shares, 4,813, 857 total shares. Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, subscribed to 469,255 shares, ISIN NO0013536078, at NOK 3.30 per share, and Anders Storbråten, CEO and ...

 PRESS RELEASE

Mandatory notice of shareholding 22 August 2025

Mandatory notice of shareholding 22 August 2025 Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. The Tranche 2 shares subscription andallocation have been completed on 20 August 2025. Altea AS will hold 5,347,321 shares in IDEX. The ownership will represent 10,26% of the shares and voting rights in IDEX. About this notice: The information shall be disclosed according to section 4-2 of the Norwegian Securities Trading Act (STA) and published in accordance with section 5-12 of the STA.

 PRESS RELEASE

Registration of share capital increase in IDEX Biometrics 22 August 20...

Registration of share capital increase in IDEX Biometrics 22 August 2025 Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share, split in two tranches. The share capital increase related to the Tranche 2 and underwriting shares have been registered and the shares will be delivered soonest. The Tranche 2 ander underwriting shares will be delivered on a separate and non-tradable ISIN, pending publication by the Company of aprospectus approved by the Norwegian Financial Supervisory Authority. Following the issue...

 PRESS RELEASE

Mandatory disclosure of holding and notice of trade in IDEX Biometrics...

Mandatory disclosure of holding and notice of trade in IDEX Biometrics – 15 August 2025 Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider. In connection with the private placement, the manager of the private placement, IDEX Biometrics and Mr. Storbråten entered into a share lending agreement. Mr. Storbråten has lent 4,359,315 shares, in connection with the settlement of Tranche 2. The shares have been lent, not...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch